OR WAIT null SECS
April 02, 2013
Continuous flow chemistry offers potential for greater control, improved safety and environmental profiles, and efficient chemical transformations.
Contract API manufacturers proceed with select investment in capacity and service additions.
March 02, 2013
As the strategic value of emerging markets increase, pharmaceutical companies increase their R&D and manufacturing investments.
FDA's requirements for API manufacturers in regards to ICH Q7.
Visual mapping can provide a particle-size distribution estimate.
Growth is seen in outsourcing of insect- and plant-cell-based bioproduction expression systems.
March 01, 2013
Pharmaceutical Technology brought together a panel of industry experts for a special forum to discuss solubilizing polymers and the related formulation strategies for poorly soluble drugs.
Factors for assessing excipient variability, the associated challenges developers need to address to design and manufacture solid oral drug products, and solutions for such challenges are examined.
The use of various documents and guides by the International Pharmaceutical Excipients Council can facilitate the flow of information among excipient manufacturers, distributors, and users.
February 06, 2013
As contract API manufacturers, fine-chemical producers, and pharmaceutical companies prepare to attend Informex in Anaheim this month, the state of the industry shows improving conditions in certain sectors.